Elanco Animal Health Inc
NYSE:ELAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elanco Animal Health Inc
NYSE:ELAN
|
US |
|
R
|
Resolute Mining Ltd
OTC:RMGGF
|
AU |
|
P
|
Pernod Ricard SA
DUS:PER
|
FR |
|
Nedap NV
F:NE3
|
NL |
|
B
|
Bank Rakyat Indonesia (Persero) Tbk PT
XBER:BYRA
|
ID |
|
Peugeot Invest SA
PAR:PEUG
|
FR |
|
J
|
Johnson Matthey PLC
XBER:JMT2
|
UK |
|
Modulight Oyj
F:78W
|
FI |
|
S
|
Serco Group PLC
XBER:SEO
|
UK |
|
S
|
Sesa SpA
SWB:1S3
|
IT |
|
Usinas Siderurgicas de Minas Gerais SA USIMINAS
F:U1S1
|
BR |
|
B
|
Bluenord ASA
OSE:BNOR
|
NO |
|
I
|
Intercontinental Exchange Inc
F:IC2
|
US |
|
M
|
Marathon Oil Corp
XMUN:USS
|
US |
|
Graphite India Ltd
NSE:GRAPHITE
|
IN |
|
6
|
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
|
US |
|
Puuilo Oyj
F:8JQ
|
FI |
|
Beauty Garage Inc
TSE:3180
|
JP |
|
R
|
Resolute Mining Ltd
XBER:RSM
|
AU |
|
D
|
Duke Energy Corp
XMUN:D2MN
|
US |
|
S
|
Stratasys Ltd
F:SCY
|
US |
|
Terumo Corp
F:TUO0
|
JP |
|
M
|
MOL Magyar Olajes Gazipari Nyrt
SWB:MOGB
|
HU |
|
Akari Therapeutics PLC
NASDAQ:AKTX
|
US |
Wall St Price Targets
ELAN Price Targets Summary
Elanco Animal Health Inc
According to Wall Street analysts, the average 1-year price target for ELAN is 30.75 USD with a low forecast of 26.26 USD and a high forecast of 33.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ELAN's stock price target?
Price Target
30.75
USD
According to Wall Street analysts, the average 1-year price target for ELAN is 30.75 USD with a low forecast of 26.26 USD and a high forecast of 33.6 USD.
What is the Revenue forecast for Elanco Animal Health Inc?
Projected CAGR
4%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Elanco Animal Health Inc?
Projected CAGR
5%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 7 years is 5%.
What is the Operating Income forecast for Elanco Animal Health Inc?
Projected CAGR
23%
Over the last 11 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 8 years is 23%.
